Drugs in R&D

译名:研发中的药物

DRUGS IN R&D

SCIEJCR Q3中科院4区

1-3

2026

影响因子区间

平台估算

投稿周期

45%

2025

中国作者发文占比

2690 EUR;3390 USD;2290 GBP

费用说明

收费

期刊简介:Drugs in R&D is an international, peer reviewed, open access, online only journal, and provides timely information from all phases of drug research and development that will inform clinical practice. Healthcare decision makers are thus provided with knowledge about the developing place of a drug in therapy.The Journal includes:Clinical research on new and established drugs;Preclinical research of direct relevance to clinical drug development;Short communications and case study reports that meet the above criteria will also be considered;Reviews may also be considered.

【译文】这是一本国际性的、同行评审的、开放获取的、仅在线的期刊,提供了关于药物研发所有阶段的信息,这些信息将有助于临床实践。因此,医疗决策者可以了解药物在治疗中的发展位置。该期刊包括:新药和现有药物的临床研究;与临床药物开发直接相关的临床前研究;符合上述标准的简报和案例研究报告也将被考虑;评论也可能被考虑。

出版社
Adis, Springer Healthcare
语言
English
学科
医学
ISSN
1174-5886
eISSN
1179-6901
出版频率
4期/年
创刊年份
1999
投稿网址
https://www.editorialmanager.com/drda
最近更新
2026-04-02 18:16:40
Drugs in R&D

指标当前值近三年趋势
JCR分区Q3
暂无
中科院分区4区
暂无
影响因子区间1-3
暂无